Volume 64, Issue 3 , Pages 390-396, March 2006
Enhanced Susceptibility of Mouse Squamous Cell Carcinoma to Photodynamic Therapy Combined With Low-Dose Administration of Cisplatin
Purpose
We have investigated the antitumor effect of photodynamic therapy (PDT), using Photofrin as the photosensitizer, combined with low-dose cisplatin (CDDP) on NR-S1 mouse squamous cell carcinoma.
Materials and Methods
CDDP (5 mg/kg body weight) was injected intraperitoneally either 1 hour or 3 hours prior to PDT or immediately afterward. Twenty-four hours after each protocol, the antitumor effects were evaluated by percentage area of the tumor necrosis in hematoxylin-eosin stained specimens as well as terminal deoxynucleotidyl transferase-mediated d-UTP nick-end labeling indices. Furthermore, the tumor sizes were evaluated at 3, 7, and 10 days after each protocol.
Results
The antitumor effect of PDT was enhanced by administration of CDDP 3 hours before PDT, whereas the administration of CDDP 1 hour before PDT or immediately after PDT did not potentiate a PDT antitumor effect.
Conclusion
Administration of low-dose CDDP 3 hours before PDT appears to be a useful treatment modality.
To access this article, please choose from the options below
Received from the Division of Oral and Maxillofacial Surgical Reconstruction and Restoration, Department of Developmental and Reconstructive Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
PII: S0278-2391(05)01826-4
doi:10.1016/j.joms.2005.11.011
© 2006 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Volume 64, Issue 3 , Pages 390-396, March 2006
